Nevada
|
000-50133
|
82-0490737
|
||
(State
or other jurisdiction
|
(Commission
|
(I.R.S.
Employer
|
||
of
incorporation)
|
File
Number)
|
Identification
No.)
|
1787
East Ft. Union Blvd., Suite 202
Salt
Lake City, Utah
|
84121
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Exhibit
No.
|
Description
|
|
10.1
|
Securities
Purchase Agreement dated November 27, 2007 by and among the Company
and
New Millennium Capital Partners II, LLC, AJW Master Fund, Ltd. and
AJW
Partners, LLC
|
|
10.2
|
Form
of Callable Secured Convertible Note dated November 27,
2007
|
|
10.3
|
Form
of Stock Purchase Warrant dated November 27, 2007
|
|
10.4
|
Registration
Rights Agreement dated November 27, 2007 by and among the Company
and New
Millennium Capital Partners II, LLC, AJW Master Fund, Ltd. and AJW
Partners, LLC
|
|
|
Security
Agreement dated November 27, 2007 by and among the Company and New
Millennium Capital Partners II, LLC, AJW Master Fund, Ltd. and AJW
Partners, LLC
|
|
10.6
|
Intellectual
Property Security Agreement dated November 27, 2007 by and among
the
Company and New Millennium Capital Partners II, LLC, AJW Master Fund,
Ltd.
and AJW Partners, LLC
|
Grant
Life Sciences, Inc.
|
||
Date:
November 29, 2007
|
By:
|
/s/
Doyle R. Judd
|
Name:
|
Doyle
R. Judd
|
|
Title:
|
Chief
Financial Officer
|